Key informationStudy endpoints- Percentage of responders in clinical cure - Improved symptoms - Quantification of the...
![[CASE STUDY] Evaluation of the efficacy, safety, and dose-response of a Live Biotherapeutic Product in women with acute vaginal infection](https://www.biofortis.fr/wp-content/uploads/2024/10/Vaginal-infection-940x675.png)
Case studies_Clinical
![[CASE STUDY] Evaluation of the safety and preliminary efficacy in patients with constipation](https://www.biofortis.fr/wp-content/uploads/2024/10/Constipation-940x675.png)
[CASE STUDY] Evaluation of the safety and preliminary efficacy in patients with constipation
Key informationStudy endpoints- Frequency of spontaneous bowel movement - Bowel function - Gastro intestinal...
![[CASE STUDY] Sleep pattern alterations](https://www.biofortis.fr/wp-content/uploads/2024/01/EXSPRAY-940x675.png)
[CASE STUDY] Sleep pattern alterations
Key informationMain study endpointSleep pattern analysis through actigraphy Using a connected mattress...
![[CASE STUDY] GI disorders](https://www.biofortis.fr/wp-content/uploads/2024/11/GI-disorders-400x250.png)
[CASE STUDY] GI disorders
Key informationStudy endpoints- DSFQ (abdominal pain, bloating, flautulence and borborygmi) - GI wellbeing - Stools frequency and consistency - Quality of life - HADS and PSS-10Population90 subjects with Digestive Symptoms Frequency Questionnaire (DSFQ) score ≥...
![[CASE STUDY] Evaluation of the efficacy, safety, and dose-response of a Live Biotherapeutic Product in women with acute vaginal infection](https://www.biofortis.fr/wp-content/uploads/2024/10/Vaginal-infection-400x250.png)
[CASE STUDY] Evaluation of the efficacy, safety, and dose-response of a Live Biotherapeutic Product in women with acute vaginal infection
Key informationStudy endpoints- Percentage of responders in clinical cure - Improved symptoms - Quantification of the strain in the vaginal microbiotaPopulation165 adult post-menarche womenTested productLive Biotherapeutic Product (LBP), tabletsInvestigations10...
![[CASE STUDY] Evaluation of the safety and preliminary efficacy in patients with constipation](https://www.biofortis.fr/wp-content/uploads/2024/10/Constipation-400x250.png)
[CASE STUDY] Evaluation of the safety and preliminary efficacy in patients with constipation
Key informationStudy endpoints- Frequency of spontaneous bowel movement - Bowel function - Gastro intestinal symptomsPopulation126 constipated patients using opioidsTested productLive Biotherapeutic Product (LBP)Investigations3 centres in France (hospitals)Key...
![[CASE STUDY] Sleep pattern alterations](https://www.biofortis.fr/wp-content/uploads/2024/01/EXSPRAY-400x250.png)
[CASE STUDY] Sleep pattern alterations
Key informationMain study endpointSleep pattern analysis through actigraphy Using a connected mattress Population14 healthy volunteersDuration88 days of evaluationInvestigations2 centers in FranceAnalysed parameters - Sleep time - Time spent in bed- Heart rate -...
![[CASE STUDY] Efficacy and safety of a nasal spray versus placebo in the treatment of early symptoms of common cold in adults](https://www.biofortis.fr/wp-content/uploads/2023/06/Featured-image-website_-case-studies-1-400x250.png)
[CASE STUDY] Efficacy and safety of a nasal spray versus placebo in the treatment of early symptoms of common cold in adults
Key informationMain study endpoints- Change from baseline in the relief of nasal congestion - Common cold symptoms- Quality of life interfered with common coldPopulation144 subjects presenting with early symptoms of common coldTested productMedical...
![[CASE STUDY] Randomized, placebo-controlled, double-blinded study to evaluate the effect of probiotics on gut function in healthy Chinese adults](https://www.biofortis.fr/wp-content/uploads/2023/05/14-400x250.png)
[CASE STUDY] Randomized, placebo-controlled, double-blinded study to evaluate the effect of probiotics on gut function in healthy Chinese adults
Key informationMain study endpoints- Number of bowel movements - Bowel habits - Stool consistency - Severity of bloating and abdominal discomfortPopulation200 healthy subjects having ≥ 3 Bowel Movements per dayTested productDietary supplementInvestigations1 site in...